InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.20
(
0.91%
)
US TECH 100
17,173.20
(
1.85%
)
Dow Jones
38,225.66
(
0.85%
)
Brent Oil
83.72
(
0.10%
)
Bitcoin
59,704.05
(
0.99%
)
Post# of 3061
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Whos_Who

Send PM Follow Ignore
Followers 15
Posts 1122
Boards Moderated 0
Alias Born 07/28/2014

Whos_Who

Re: axle1090 post# 1946

Tuesday, 09/11/2018 6:47:37 PM

Tuesday, September 11, 2018 6:47:37 PM

Post# of 3061
Foamix as you can see is in there phase 3 Program. For them to receive positive results using Minocycline proves that they have a product that works. This builds Institutional Investor confidence in the product and investment.

Now investors will weigh in on which company would be the better investment. Foamix and their oil-based product, or BioPharmX and there water soluble product, which is a much better delivery system, and file patent secured by the way.

In other words, if Foamix flopped using Minocycline why would you want to take a risk in BioPharmX who is using the same formula. Their success brings major confidence in our much better product and delivery system!

BioPharmX is the better investment choice!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up